Aldehyde dehydrogenase‐2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP‐activated protein kinase signaling in mice
Guojun Hou, Lei Chen, Gang Liu, Liang Li, Yuan Yang, He‐Xin Yan, Hui‐Lu Zhang, Jing Tang, Ying Cheng Yang, Ximeng Lin, Xin Chen, Gui juan Luo, Yanjing Zhu, Shanhua Tang, Jin Zhang, Hui Liu, Qingyang Gu, Ling‐Hao Zhao, Yixue Li, Lei Liu, Weiping Zhou, Hongyang Wang – 27 December 2016 – Potential biomarkers that can be used to determine prognosis and perform targeted therapies are urgently needed to treat patients with hepatocellular carcinoma (HCC).